-
Public Spending on Medicines Between 2018 and 2026: Lessons for Designing a New Financing Model in Portugal
Sep 9, 2025, 16:22 PM -
Early Health Technology Assessment and Cost-Effectiveness of the National Cardiovascular Disease Prevention Program in Greece
Sep 9, 2025, 16:22 PM -
Cost Analysis of the Extravascular Implantable Cardioverter-Defibrillator Compared to the Subcutaneous System in Patients at Risk of Sudden Cardiac Death in Italy
Sep 9, 2025, 16:22 PM -
Predicting PICOs Through Machine-Learning–Powered Information Compression and Statistical Ranking
Sep 9, 2025, 16:22 PM -
When Cost-Effectiveness No Longer Counts: Industry Views on the Undermining of HTA Principles in Korea
Sep 9, 2025, 16:22 PM -
Contractual Interaction Between EPS and IPS in Colombia: Information Asymmetries Agency Theory and Efficiency in Cost Management
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of STRIDE (Tremelimumab + Durvalumab) vs. Atezolizumab + Bevacizumab for Unresectable Hepatocellular Carcinoma: Qatari Payer and Societal Perspectives
Sep 9, 2025, 16:22 PM -
A Nonactive Implant for the Treatment of Chronic Gastro-esophageal Reflux Disease: A Cost-Effectiveness Evaluation From the Perspective of German Healthcare
Sep 9, 2025, 16:22 PM -
Validation of a Natural Language Processing Solution (REALLI) Compared to Manual Review by Physicians of Electronic Health Records (EHR) From Patients With HER2+ Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Reducing Major Amputation Rates and Infectious Complications Using Bioimpression-Based Wound Management in Colombia
Sep 9, 2025, 16:22 PM -
Economic Burden of the Adverse Events During Treatment of Metastatic Breast Cancer (mBC) HR-/HER2+ Patients in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Variation in Revisions and Complications After Proximal Femoral Fracture Fixation—Association With Provider Characteristics
Sep 9, 2025, 16:22 PM -
The Impact of Early Antibacterial Therapy on ICU Patient Outcomes for Sepsis: A Causal Analysis
Sep 9, 2025, 16:22 PM -
Economic Burden of Type 1 Diabetes Mellitus After Disease Onset: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Predicting Outcomes and Estimating Minimum Sample Sizes for Divozilimab Efficacy in NMOSD: A Clinical Trial Simulation and Unanchored Matching-Adjusted Indirect Comparison
Sep 9, 2025, 16:22 PM -
Development of the Adelphi Caregiver Experience Questionnaire© (ACARE): A Novel Tool Designed to Measure and Understand the Burden and Quality of Life Impacts of the Caregiver Role
Sep 9, 2025, 16:22 PM -
Rising EAP Rejection Rates and Their Impact on Drug Access in France
Sep 9, 2025, 16:22 PM -
Evaluating Adverse Events Associated With ECMO Devices Using MAUDE Database: Monitoring the Lifeline
Sep 9, 2025, 16:22 PM -
Molecular Testing Strategies and Their Impact on Treatment Decision in HR+/HER2- Metastatic Breast Cancer: A Real-World Analysis From German Centers
Sep 9, 2025, 16:22 PM -
Reframing Pharmaceutical Pricing: Implications of the 2025 SVR Report for Germany’s Pricing Logic and International Spillovers
Sep 9, 2025, 16:22 PM